Skip to main content

ScienceDex / Researcher record

Lim, Mark

From the FY2009 NIH awards this investigator leads as contact PI. The department is the award's.

FY2009 NIH rank #3,422
  • Long-Funded

NIH Funding · FY2009

$1.9M
Full award amounts, FY2009
5
Records listing this PI
#3,422
By linked amount among FY2009 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$837,7092#6,549
2007$1,878,6404#2,969
2008$1,924,1234#2,584
2009$1,940,7905#3,422
2010$608,1342#14,615
2011$149,8651#34,907
2012$1,285,3244#5,098
2013$1,135,4593#5,468
2014$1,986,4383#2,939
2015$1,498,6492#4,130
2016$1,977,4053#2,794
2017$753,5001#10,049
2018$1,991,4873#2,880
2019$1,999,7442#3,153
2021$1,249,9581#6,963
2022$3,417,6853#1,405
2023$2,970,1033#1,869

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20062 records
  2. FY20074 records
  3. FY20084 records
  4. FY2009 · selected5 records
  5. FY20102 records
  6. FY20111 record
  7. FY20124 records
  8. FY20133 records
  9. FY20143 records
  10. FY20152 records
  11. FY20163 records
  12. FY20171 record
  13. FY20183 records
  14. FY20192 records
  15. FY20211 record
  16. FY20223 records
  17. FY20233 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Lim, Mark. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2009 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2009 award records by amount

NIH award records listing Lim, Mark as a PI. Multi-PI records show the full award amount for context.

  • 5R44AI052525-05R44Contact PI
    Novel Proteomic Arrays of In Vitro Expressed Proteins for Autoimmune Disease
    $657.6K
    award amount
  • 5R44CA114126-03R44Contact PI
    ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
    $420K
    award amount
  • 3R44CA114126-03S1R44Contact PI
    ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
    $399K
    award amount
  • 5R44NS053110-04R44Contact PI
    Advanced Molecular Diagnostic Test for Neurofibromatosis
    $383.3K
    award amount
  • 3R44AI052525-05S1R44Contact PI
    Novel Proteomic Arrays of In Vitro Expressed Proteins for Autoimmune Disease
    $80.9K
    award amount

Award organization

Organizations that administered FY2009 awards listing Lim, Mark as a PI.

FY2009 award administered by Ambergen, Inc ().

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Ambergen, Inc
  2. 2006
    $500K Cumulative Funding
  3. 2006
    Entered Top 50% Nationally
    Ranked #6549
  4. 2007
    $1M Cumulative Funding
  5. 2007
    $2M Cumulative Funding
  6. 2007
    Entered Top 25% Nationally
    Ranked #2969
  7. 2009
    $5M Cumulative Funding
  8. 2014
    $10M Cumulative Funding
  9. 2022
    Entered Top 10% Nationally
    Ranked #1405
  10. 2023
    $25M Cumulative Funding